
Welcome to the Royal College of Pharmacy
We’ve changed. You may know us as the Royal Pharmaceutical Society — on 15 April 2026, we became the Royal College of Pharmacy.


We are the Royal College of Pharmacy, the professional leadership body for pharmacists and pharmaceutical scientists. We exist to advance the safe and effective use of medicines, drive excellence in patient care and support pharmacists to deliver the highest standards of practice.
As the third largest workforce in healthcare, pharmacy plays a vital role in the health system, and as experts in medicines, pharmacists and their teams are central to patient care and public health. Our mission is to put pharmacy at the forefront of patient care, advancing the safe and effective use of medicines to the benefit of patients and the public.





Have any questions or comments on the new Royal College website?
Please visit our support page or email [email protected]
News
The latest news and updates from Royal College of Pharmacy
-
Health Committee publishes pharmacy report
This news story was published when the organisation was the Royal Pharmaceutical Society. The Royal Pharmaceutical Society (RPS) has welcomed a new report by the House of Commons Health and Social Care Select Committee, following its inquiry into pharmacy. We engaged extensively with the Committee throughout the process, submitting written evidence, attending a roundtable event, and giving evidence in person at a public hearing. RPS director for England James Davies gave evidence to the Committee in November 2023 and highlighted key issues around workforce planning, wellbeing and protected learning time, investment in pharmacy students through the Learning Support Fund, medicines shortages, and interoperable patient records. The Committee has subsequently made a number of recommendations, addressing many RPS key policy asks: Reviewing the effectiveness of Serious Shortage Protocols Enabling pharmacists in community settings to make substitutions to help manage medicines shortages An independent review of the medicines supply chain Further development of clinical services in community pharmacy settings Provision of HIV-prevention medication PrEP through community pharmacy Interoperable read/write access to patient records in community pharmacy Reform of the Community Pharmacy Contractual Framework Enabling pharmacy students to access the Learning Support Fund Ensuring that all pharmacists have adequate access to supervision, training, and protected learning time, along with clear structures for professional career development An independent review of hospital medicines management. Tase Oputu, RPS England Chair, said: “Today’s report acknowledges the vital role of pharmacists and pharmacy teams across the whole health service and also sets out some key challenges that need to be addressed urgently. “Our evidence to the Committee highlighted RPS key campaign issues around workforce planning, wellbeing and protected learning time, investment in pharmacy students through the Learning Support Fund and much-needed investment in IT and interoperable patient records. “While we have seen some welcome progress towards advancing the clinical role of pharmacists in the NHS, the report shows there is still more to do to make the most of the growing number of pharmacist prescribers. “The Committee has rightly recognised the growing impact of medicines shortages on patient care and the widespread support for reform. Our investigation into medicines shortages will report on this later in the year. “Whoever wins the general election, this report sets out clear priorities for pharmacy and there’s no doubt the next government must act on today’s recommendations and put improving patient care at the heart of its agenda.” Read the full report. Watch Davies giving evidence to the Committee below. https://youtu.be/W6380iUDjcY Davies also talks about expanding the role of pharmacists beyond hospitals. He mentions the future integration of prescribing skills for all newly qualified pharmacists starting in 2026, making best use of the skill mix within the entire pharmacy team, and exploring opportunities in clinical trials and the life science sector. Watch below. https://youtu.be/ByY2hIblKGg Watch the committee session Read our written evidence to the committee. Support pharmacy in the general election by sharing our manifesto. Read more RCPharm news stories.
-
RPS launches new prescribing support service
We’re excited to announce the launch of our new Prescribing Support Service, an extension of our Professional Support Service tailored to queries about prescribing.
-
Professor Ryan Donnelly awarded 2024 RPS Harrison Medal
This news story was published when the organisation was the Royal Pharmaceutical Society. We’re pleased to announce that Professor Ryan Donnelly has been awarded the RPS Harrison Memorial Medal for 2024 for his outstanding contribution to advancing pharmaceutical science. The medal is awarded every two years, in memory of the distinguished pharmaceutical chemist Col EF Harrison. Professor Ryan Donnelly is Chair in Pharmaceutical Technology at Queen’s University Belfast’s School of Pharmacy and Director of Research. A registered pharmacist, his expertise lies in developing advanced polymeric drug delivery systems for transdermal and intradermal drug delivery, aimed at improving patient outcomes. Collaborating with major pharmaceutical companies, he is developing a range of novel microneedle technologies. His work has attracted over £30m in funding and he has authored more than 1,000 peer-reviewed publications, including patent applications, textbooks, book chapters and full papers. He also leads a diverse research team of 50 individuals from 15 different countries and has been an invited speaker at numerous national and international conferences. His contributions have earned him prestigious awards, including the International Association for Pharmaceutical Technology Research Award for Outstanding Achievements in the Pharmaceutical Sciences (2024) and the Kydonieus Foundation Transdermal Delivery Award (2024). Professor Donnelly also won the European Journal of Pharmaceutics and Biopharmaceutics Most Cited Paper Award in 2023, Visit Belfast’s Ambassador Award for Life and Health Sciences in 2022, and many more throughout his career. As Europe/Africa Editor of Drug Delivery and Translational Research, Professor Donnelly continues to shape the field with his groundbreaking research and commitment to pharmaceutical science. Professor Donnelly said: “I am delighted to receive this great honour from RPS. As a pharmacist, my work has always focused on harnessing the pharmaceutical sciences to develop drug and vaccine delivery systems that can enhance therapeutic outcomes for patients. That these efforts have been recognised by such a prestigious award emphasises the importance of the application of scientific knowledge by the pharmacy profession.” Professor Parastou Donyai, RPS Chief Scientist said: “It is a real pleasure to announce Professor Ryan Donnelly as the 2024 RPS Harrison Medal winner. Professor Donnelly is a world leader in the field of drug delivery. His novel inventions have the potential for genuine impact, and his publication record, substantial research funding, and investment in developing others attest to his authority and distinction. Professor Donnelly is a credit to pharmaceutical science and the whole of the profession of pharmacy.” More on the Harrison Memorial Medal. Read more RCPharm news stories